2-allyl-1-tosyl-1H-indole | 1257657-39-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-allyl-1-tosyl-1H-indole
• 英文别名: 2-allyl-1-(toluene-4-sulfonyl)-1H-indole；1-(4-Methylphenyl)sulfonyl-2-prop-2-enylindole
• CAS: 1257657-39-8
• 化学式: C₁₈H₁₇NO₂S
• 分子量: 311.404
• InChiKey: JKYJZVMTRLPKLV-UHFFFAOYSA-N

物化性质

• 沸点：
  490.0±53.0 °C(Predicted)
• 密度：
  1.16±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  47.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-allyl-1-tosyl-1H-indole 在 四氯化钛 sodium chlorite 、 sodium dihydrogenphosphate 作用下， 以 反-2-戊烯 、 二氯甲烷 、 水 、 叔丁醇 为溶剂， 反应 29.0h， 生成 2-allyl-1-tosyl-1H-indole-3-carboxylic acid
  参考文献：
  名称：

  NON-NATURAL MACROCYCLIC AMIDE HDAC6 INHIBITOR COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS

  摘要：

  本发明涉及一种新型式I的酰胺化合物，以及其作为抗肿瘤和促凋亡剂的用途。该发明涉及这些化合物在医学中的应用，涉及癌症疾病以及其他需要抑制HDAC6的疾病，以及含有这些化合物的药物组合物。

  公开号：

  US20120258993A1
• 作为产物：
  描述：

  1-戊烯-4-炔 在 吡啶 、 bis-triphenylphosphine-palladium(II) chloride 、 N-碘代丁二酰亚胺 、 copper(l) iodide 、 palladium diacetate 、 potassium carbonate 、 三乙胺 、 lithium iodide 作用下， 以 四氢呋喃 、 二氯甲烷 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 45.5h， 生成 2-allyl-1-tosyl-1H-indole
  参考文献：
  名称：

  钯催化合成二氢环辛八烯[ b ]吲哚及其与马来酰亚胺或马来酸酐的热反应性

  摘要：

  AbstractA palladium(0)‐catalyzed reaction of 2‐allyl‐3‐indolyl boronates/propargylic carbonates was observed to afford dihydrocycloocta[b]indoles highly efficiently via carbon‐carbon coupling, [1,5]‐hydrogen migration involving dearomatization, and electrocyclization involving rearomatization. Their thermal reactions with the addition of dienophiles involving eletrocyclization and [4+2] cycloaddition have been studied.magnified image

  DOI：

  10.1002/adsc.201400644

文献信息

• Non-Natural Macrocyclic Inhibitors of Histone Deacetylases: Design, Synthesis, and Activity
  作者：Luciana Auzzas、Andreas Larsson、Riccardo Matera、Annamaria Baraldi、Benoît Deschênes-Simard、Giuseppe Giannini、Walter Cabri、Gianfranco Battistuzzi、Grazia Gallo、Andrea Ciacci、Loredana Vesci、Claudio Pisano、Stephen Hanessian

  DOI：10.1021/jm101092u

  日期：2010.12.9

  inhibitory profile was observed for several compounds, which was comparable, if not superior, to that of 2. A promising cytotoxic activity was found for selected macrocycles against lung and colon cancer cell lines. Further elaboration of selected candidates led to compounds with an improved selectivity against HDAC6 over the other isozymes. Pair-fitting analysis was used to compare one of the best

  非肽手性大环化合物是基于辛二酰苯胺异羟肟酸（2）（SAHA，vorinostat）的类似物设计的，并针对11种组蛋白脱乙酰基酶（HDAC）同工型进行了评估。HDACs帽区域中高度保守的关键氨基酸残基的鉴定指导了基于亚油酰基的大环的设计，预计这些大环具有靶向整个HDAC面板所需的最大通用亚结构。观察到了几种化合物的纳摩尔HDAC抑制谱，即使不是更好，也可与2种相比。。发现针对肺癌和结肠癌细胞系的选定大环化合物有希望的细胞毒性活性。进一步精制选定的候选物，使得化合物对HDAC6的选择性优于其他同工酶。使用配对拟合分析将最佳候选之一与天然四肽阿匹西丁进行比较，以定义一种通用药效团，该药效团可能在设计肽类大环化合物的替代物时作为有效的和同工型选择性抑制剂。
• One-Pot Approach to Installing Eight-Membered Rings onto Indoles
  作者：Can Zhu、Xue Zhang、Xiongdong Lian、Shengming Ma

  DOI：10.1002/anie.201202971

  日期：2012.7.27

  Ring fusion: The Pd0‐catalyzed reaction of 2‐allyl‐3‐iodo‐1‐tosyl‐1H‐indoles and propargylic bromides affords dihydrocycloocta[b]indoles (see scheme; M.S.=molecular sieves, TFP=tris(2‐furyl)phosphine, Ts=4‐toluenemethanesulfonyl), and proceeds by carbon–carbon coupling, [1,5]‐hydrogen migration, and electrocyclization. The newly established method was used to efficiently access iprindole.

  环融合：2-烯丙基-3-碘-1--1-甲苯磺酰基-1 H-吲哚与炔丙基溴的Pd 0催化反应可得到二氢环辛八烯[ b ]吲哚（参见示意图； MS =分子筛，TFP = tris（2−呋喃基膦，Ts = 4-甲苯甲磺酰基），并通过碳-碳偶合，[1,5]-氢迁移和电环化进行。新建立的方法用于有效地访问艾普琳。
• Catalytic C-2 Allylation of Indoles by Electronic Modulation of the Indole Ring and its Application to the Synthesis of Functionalized Carbazoles
  作者：Ju Young Lee、Hyeri Ha、Seri Bae、Inhyuk Han、Jung Min Joo

  DOI：10.1002/adsc.201600568

  日期：2016.11.3

  We report a palladium‐catalyzed C‐2 allylation of indoles and subsequent cyclization of the allylated indoles. The electronic effects of chloro and ester groups that can be readily installed at the C‐3 position of indoles facilitated a highly efficient C–H allylation at the C‐2 position. The resulting 2‐allyl‐3‐chloroindoles were found to be suitable substrates for benzannulation reactions with alkynes

  我们报道了钯催化的吲哚的C-2烯丙基化以及随后的烯丙基化的吲哚的环化反应。可以容易地将吲哚的C-3位置安装的氯和酯基团的电子效应促进了C-2位置的高效C-H烯丙基化。发现生成的2烯丙基3氯吲哚是与炔烃和降冰片二烯作为乙炔合成子进行苯环化反应的合适底物。这种方法利用容易获得的吲哚，乙酸烯丙酯和降冰片二烯，可以快速获得复杂的咔唑。
• AMIDE COMPOUNDS AND THEIR USE AS ANTITUMOR AGENTS
  申请人：Hanessian Stephan

  公开号：US20100113504A1

  公开（公告）日：2010-05-06

  The present invention relates to a compound of Formula (I), its geometrical isomers, in an optically active form as enantiomers, diastereomers, as well as in the form of racemate, as well as pharmaceutically acceptable salts thereof, wherein R is selected from CONHOH, CONHCH 2 SH, CONHCH 2 SCOCH 3 , SH, SCOCH 3 , SCH 3 , N(OH)COH, COCONHCH 3 and CF 3 for the preparation of a medicament, in particular for selectively inducing terminal differentiation of neoplastic cells and thereby inhibiting proliferation of such cells, for inducing differentiation of tumor cells in a tumor, for inhibiting the activity of histone deacetylase and for the treatment of primary cancer or secondary cancer.

  本发明涉及一种公式(I)的化合物，其几何异构体，以光学活性形式作为对映体，对映异构体，以及盐的形式，其中R选自CONHOH，CONHCH2SH，CONHCH2SCOCH3，SH，SCOCH3，SCH3，N（OH）COH，COCONHCH3和CF3，用于制备药物，特别是用于选择性诱导肿瘤细胞的终端分化，从而抑制这些细胞的增殖，诱导肿瘤中肿瘤细胞的分化，抑制组蛋白去乙酰化酶的活性以及治疗原发性癌症或转移性癌症。
• [EN] NON-NATURAL MACROCYCLIC AMIDE HDAC6 INHIBITOR COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS<br/>[FR] COMPOSÉS AMIDES MACROCYCLIQUES NON NATURELS INHIBITEURS DE HDAC6 ET LEURS UTILISATIONS EN TANT QU'AGENTS THÉRAPEUTIQUES
  申请人：SIGMA TAU IND FARMACEUTI

  公开号：WO2011047926A1

  公开（公告）日：2011-04-28

  The present invention relates to novel amide compounds of formula I, and their use as anti-tumoral and pro-apoptotic agents. The invention includes the use of such compounds in medicine, in relation to cancer disease as well as other diseases where an inhibition of HDAC6 is responsive, and the pharmaceutical composition containing such compounds.